Biogen at the brink, Pfizer's big bet and other takeaways from a quiet JPM
The banality of Zoom and absence of a big buyout notwithstanding, a flurry of licensing deals kept things interesting.
Source: mmm-online.com
Stay updated with breaking news from Umer Raffat. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The banality of Zoom and absence of a big buyout notwithstanding, a flurry of licensing deals kept things interesting.
In this article, we discuss the 10 healthcare dividend stocks with over 3% yield.
New coronavirus variant likely to be more transmissible but less severe, Fauci says
New coronavirus variant likely to be more transmissible but less severe, Fauci says